Which occupational disease is characterized by the formation of beryllium-protein complexes that trigger a cell-mediated hypersensitivity reaction?

Explanation

## Chronic Beryllium Disease (CBD) **Key Point:** CBD is a granulomatous lung disease caused by inhalation of beryllium dust or fumes in occupational settings. The disease is mediated by a cell-mediated (Type IV) hypersensitivity reaction to beryllium-protein complexes. ### Pathophysiology **High-Yield:** Beryllium is a highly toxic metal that acts as a hapten, binding to lung proteins to form immunogenic complexes. These complexes are presented to T lymphocytes, triggering a chronic inflammatory response. ### Two-Stage Disease Process | Stage | Mechanism | Clinical Features | |-------|-----------|-------------------| | **Acute beryllium disease** | Acute inflammatory response to beryllium dust | Cough, dyspnea, chest pain; resolves with exposure cessation | | **Chronic beryllium disease (CBD)** | Persistent cell-mediated immunity; granuloma formation | Progressive dyspnea, restrictive lung disease, non-caseating granulomas on biopsy | ### Diagnostic Approach 1. **Beryllium lymphocyte proliferation test (BeLPT)**: Gold standard for detecting beryllium sensitization 2. **Chest X-ray**: Shows diffuse nodular infiltrates or hilar lymphadenopathy 3. **Lung biopsy**: Non-caseating granulomas (similar to sarcoidosis) **Mnemonic: CBD = Cell-mediated, Beryllium, Disease** — remember it is immune-mediated, not direct cytotoxicity. **Clinical Pearl:** Beryllium is used in aerospace, electronics, nuclear, and dental prosthetics industries. Workers in these sectors require strict exposure controls and medical surveillance.